"Prof Rosell's contributions range from tumor biology and prognostic and treatment-predictive markers, to clinical trials involving chemotherapy and targeted agents with careful dedication to personalized medicine," said Dr Tabernero.
The Hamilton Fairley Award commemorates one of the founding fathers of Medical Oncology in Europe and is presented to candidates who are internationally recognized for lifetime achievements in science and clinical/laboratory research.
"Nowadays, clinical achievements are basically propelled by translational research and therefore this award is a recognition of a multidisciplinary effort," Prof Rosell said. "It is a great honor for me to receive this award, but more importantly, I believe that the award is a recognition of the collective group of clinical and laboratory investigators, as well as statisticians and other key persons involved."
The ESMO Lifetime Achievement Award in 2011 goes to Prof Hans Jrg Senn of the Tumor and Breast Centre ZeTuP, in St Gallen, Switzerland.
"Prof Senn is being recognized for his work in organizing educational activities, which set the standards of care in breast cancer, mainly in relation to adjuvant treatment, as well as bringing prevention strategies to Medical Oncologists in Europe," said Prof Franco Cavalli, Chair of the ESMO Lifetime Achievement Award Committee. "His outstanding efforts through the organization of Consensus Conferences among breast cancer experts focused attention on addressing subtle questions in the adjuvant treatment of breast cancer, which presented a dilemma for practicing physicians."
|Contact: Vanessa Pavinato|
European Society for Medical Oncology